Bicycle Therapeutics (BCYC) Shares Outstanding (2018 - 2026)

Bicycle Therapeutics has reported Shares Outstanding for 9 years, with the latest figure at $69.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 0.73% year-over-year to $69.7 million; the trailing twelve-month figure through Mar 2026 stood at $69.7 million (up 0.73% YoY), and the FY2025 full-year result was $69.4 million, changed 0.44% from the prior year.
• Shares Outstanding for Q1 2026 stood at $69.7 million, roughly flat from $69.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $69.7 million in Q1 2026, with the low at $29.6 million in Q1 2022.
• Historically, Shares Outstanding has averaged $50.6 million across 5 years, with a median of $42.6 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding soared 125.4% — and 2025, when it increased 0.42%.
• Bicycle Therapeutics' Shares Outstanding stood at $29.9 million in 2022, then surged by 42.04% to $42.4 million in 2023, then soared by 62.76% to $69.1 million in 2024, then grew by 0.44% to $69.4 million in 2025, then climbed by 0.49% to $69.7 million in 2026.
• The last three Shares Outstanding figures came in at $69.7 million (Q1 2026), $69.4 million (Q4 2025), and $69.3 million (Q3 2025), per Business Quant data.